| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/16/1999 | WO1999045969A2 Radioimmuno-pharmacon for treating the hiv-1 infection |
| 09/16/1999 | WO1999045961A1 Tertiary structure of peanut allergen ara h 1 |
| 09/16/1999 | WO1999045960A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 09/16/1999 | WO1999045959A1 Humanized antibody and uses thereof |
| 09/16/1999 | WO1999045957A2 Combined vaccine compositions |
| 09/16/1999 | WO1999045956A1 Vaccines against circovirus infections |
| 09/16/1999 | WO1999045954A1 Hla-binding peptides and their uses |
| 09/16/1999 | WO1999045948A1 Reagents for detection and treatment of kaposi's sarcoma |
| 09/16/1999 | WO1999045904A1 Delivery system to modulate immune response |
| 09/16/1999 | WO1999045903A1 Colonic delivery of protein or peptide compositions |
| 09/16/1999 | WO1999036091A3 Method for inhibiting cd95-independent apoptosis in aids |
| 09/16/1999 | WO1999034823A3 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |
| 09/16/1999 | WO1999033868A3 Human papillomavirus vaccine |
| 09/16/1999 | WO1999033522A3 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
| 09/16/1999 | WO1999032633A8 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof |
| 09/16/1999 | WO1999015666A3 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof |
| 09/16/1999 | WO1999015657A3 53bp2 complexes |
| 09/16/1999 | WO1999009177B1 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
| 09/16/1999 | WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/16/1999 | DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents |
| 09/16/1999 | CA2421394A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421388A1 Novel poypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421375A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421372A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421364A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421345A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421329A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421319A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421315A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421286A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421278A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421272A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2323787A1 Humanized antibody and uses thereof |
| 09/16/1999 | CA2323632A1 Hla-binding peptides and their uses |
| 09/16/1999 | CA2323236A1 Human receptor proteins; related reagents and methods |
| 09/16/1999 | CA2323210A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 09/16/1999 | CA2323070A1 Chitinase chitin-binding fragments |
| 09/16/1999 | CA2323062A1 Colonic delivery of protein or peptide compositions |
| 09/16/1999 | CA2322472A1 Delivery system to modulate immune response |
| 09/15/1999 | EP0941738A1 Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
| 09/15/1999 | EP0941478A1 Assay method for peptide specific t-cells |
| 09/15/1999 | EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system |
| 09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 09/15/1999 | EP0941342A1 Human squalene epoxidase |
| 09/15/1999 | EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 09/15/1999 | EP0941337A1 Synthesis and purification of hepatitis c virus-like particles |
| 09/15/1999 | EP0941336A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
| 09/15/1999 | EP0941335A2 Streptococcus pneumoniae polynucleotides and sequences |
| 09/15/1999 | EP0941333A1 Immunogenic detoxified mutant e. coli lt-a toxin |
| 09/15/1999 | EP0941328A1 Human breast tumor-specific proteins |
| 09/15/1999 | EP0941327A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 09/15/1999 | EP0941326A1 Murine guanine nucleotide exchange factor (mngef) and human homologues thereof |
| 09/15/1999 | EP0941322A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
| 09/15/1999 | EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 09/15/1999 | EP0941319A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences |
| 09/15/1999 | EP0941317A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941315A1 Immune responses using compositions containing stress proteins |
| 09/15/1999 | EP0941252A1 Anti-p53 single-chain antibody fragments and their uses |
| 09/15/1999 | EP0941251A1 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
| 09/15/1999 | EP0941249A1 Novel histamine h2 receptor |
| 09/15/1999 | EP0941248A1 Platelet secretory transport protein |
| 09/15/1999 | EP0941241A1 $i(BORDETELLA) STRAIN EXPRESSING THE FHA HYBRID, LIPOSOMES AND VACCINES |
| 09/15/1999 | EP0941240A1 New picornaviruses, vaccines and diagnostic kits |
| 09/15/1999 | EP0941121A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |
| 09/15/1999 | EP0941120A1 Branched peptide linkers |
| 09/15/1999 | EP0941119A1 Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation |
| 09/15/1999 | EP0941118A2 Pharmaceutical antigen-antibody preparation |
| 09/15/1999 | EP0941117A1 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids |
| 09/15/1999 | EP0941111A1 Hepatocyte growth factor antagonists |
| 09/15/1999 | EP0941082A2 New use for 1,3-propanediol derivatives |
| 09/15/1999 | EP0941067A2 Stable glassy state powder formulations |
| 09/15/1999 | EP0611304B1 Use of acetylated mannan (acemannan) for the regulation of blood cholesterol levels and for removing plaques in blood vessels |
| 09/15/1999 | EP0567470B1 Pseudomonas peptide composition and method for producing the same |
| 09/15/1999 | CN1228709A Multivalent DTP-POLID vaccines |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952472 Anti-fibroblast growth factor-8 monoclonal antibody |
| 09/14/1999 | US5952454 Linking compounds useful for coupling carbohydrates to amine-containing carriers |
| 09/14/1999 | US5952227 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same |
| 09/14/1999 | US5952225 A packaging cell containing a polynucleotide which codes a portion of a selected retrovirus having at least the envelope protein; for producing vectors resistant to complement inactivation by serum; gene therapy |
| 09/14/1999 | US5952212 Anticarcinogenic agents and antidiabetic agents |
| 09/14/1999 | US5952199 A protein that contains an immunoglobulin-like domain; antiproliferative/antitumor agents, treatment of rheumatoid arthritis, psoriasis, diabeties, glaucoma, muscular disorders and immune rejection of eye transplants |
| 09/14/1999 | US5952196 A polynucleotide from streptococcus; for screening bactericides and antibiotics, diagnosis pneumonia, bacterial meningitis, sinusitis, conjuctivitis and infections of the cerebrospinal fluid |
| 09/14/1999 | US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease |
| 09/14/1999 | US5952175 DNA encoding a human progesterone receptor complex p23-like protein |
| 09/14/1999 | US5952034 Increasing the digestibility of food proteins by thioredoxin reduction |
| 09/14/1999 | US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/14/1999 | US5951988 Comprising a quaternary ammonium salt in a compatible solvent e.g. a lower alkanol, emulsifier, an oil and buffer; vaccine; viruses; veterinary medicine |
| 09/14/1999 | US5951987 Polysaccharide vaccine to enhance immunity against brucellosis |
| 09/14/1999 | US5951986 Tandem synthetic HIV-1 peptides |
| 09/14/1999 | US5951985 Tumor associated epitope |
| 09/14/1999 | US5951984 Administering immunogen selected from group of protein and peptide to mammel, wherein mammel does not ingest a fat-soluble component substance within 4 hours before and within 2 hours after ingestion of the immunogen |
| 09/14/1999 | US5951982 Administering an antibody thaat binds an epitope of vcd44; antitumor,-metastasis and carciogenic agents |
| 09/14/1999 | US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33 |
| 09/14/1999 | US5951975 Immunization with a foreign artificial target antigen to promote a cytotoxic t-lymphocyte response; loading cultured tumor cells with antigen; deactivating the cells; immunizing with the cell to get a response to unmodified tumor |
| 09/14/1999 | CA2132208C Method of eliminating inhibitory/instability regions of mrna |
| 09/14/1999 | CA1340747C Hiv-2 virus variants |
| 09/14/1999 | CA1340737C Process for the preparation of pasteurized immunoglobulin preparation |